Patent · US Active

Quinoxaline derivatives and their use for treating benign and malignant tumour disorders

US8394801B2 · kind B2 · utility

0Cited by

1References

12Claims

0Family size

Assignee

Aeterna Zentaris, Inc. · DE

Inventors

Matthias Gerlach · Wächtersbach, DE
Irene Seipelt · Offenbach, DE
Eckhard Guenther · Maintal, DE
Tilmann Schuster · Großostheim, DE
Emmanuel Polymeropoulos · Frankfurt, DE
Michael P. Czech · Frankfurt am Main, DE
Eckhard Claus · Frankfurt, DE

Key dates

Filing date	Mar 25, 2010
Grant date	Mar 12, 2013
Priority date	—
Expiry date	Mar 25, 2030

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D413/12
WIPO fieldOrganic fine chemistry
WIPO sectorChemistry

Abstract

The invention provides quinoxalines of the general formula I which are used as medicaments preferably for treating tumour disorders, in particular in cases of drug resistance to other active compounds and in cases of metastasic carcinoma. The possible applications are not limited to tumour disorders.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.